相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amnestic MCI Patients' Perspectives toward Disclosure of Amyloid PET Results in a Research Context
Gwendolien Vanderschaeghe et al.
NEUROETHICS (2017)
Communicating mild cognitive impairment diagnoses with and without amyloid imaging
Joshua D. Grill et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Patient and caregiver reactions to clinical amyloid imaging
Joshua D. Grill et al.
ALZHEIMERS & DEMENTIA (2017)
Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability
Yen Ying Lim et al.
ALZHEIMERS & DEMENTIA (2016)
Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment
Jennifer H. Lingler et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review
S. A. S. A. Bemelmans et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results
Jonathan Gooblar et al.
JAMA NEUROLOGY (2015)
Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment
Vanessa Lawrence et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what to tell. A kickstart to an ethical discussion
Corinna Porteri et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Disclosure of amyloid imaging results to research participants: Has the time come?
Jennifer H. Lingler et al.
ALZHEIMERS & DEMENTIA (2013)
DEMENTIA Disclosure of results to participants in dementia research
Serge Gauthier et al.
NATURE REVIEWS NEUROLOGY (2013)
Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues
S. Gauthier et al.
PROGRESS IN NEUROBIOLOGY (2013)
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
Rik Vandenberghe et al.
NEUROIMAGE-CLINICAL (2013)
Decision-making in older people with dementia
M. Aurora Viloria Jimenez et al.
REVIEWS IN CLINICAL GERONTOLOGY (2013)
Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues
J. Scott Roberts et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2013)
Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment
Pieter Jelle Visser et al.
BIOMARKERS IN MEDICINE (2012)
QUAGOL: A guide for qualitative data analysis
Bernadette Dierckx de Casterle et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2012)
Disclosure of Individualized Research Results: A Precautionary Approach
David B. Resnik
ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls
Henryk Barthel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Feedback of Individual Genetic Results to Research Participants: In Favor of a Qualified Disclosure Policy
Annelien L. Bredenoord et al.
HUMAN MUTATION (2011)
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
Henryk Barthel et al.
LANCET NEUROLOGY (2011)
Ethical considerations of biomarker use in neurodegenerative diseases-A case study of Alzheimer's disease
David Prvulovic et al.
PROGRESS IN NEUROBIOLOGY (2011)
Disclosure of individual genetic data to research participants: the debate reconsidered
Annelien L. Bredenoord et al.
TRENDS IN GENETICS (2011)
Early dementia diagnosis and the risk of suicide and euthanasia
Brian Draper et al.
ALZHEIMERS & DEMENTIA (2010)
Researcher Practices on Returning Genetic Research Results
Christopher Heaney et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2010)
I know what you told me, but this is what I think: Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate
Erin Linnenbringer et al.
GENETICS IN MEDICINE (2010)
Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions
J. Scott Roberts et al.
FUTURE NEUROLOGY (2010)
Biomarkers, Dementia, and Public Health
C. F. Wright et al.
BIOMARKERS IN BRAIN DISEASE (2009)
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
Robert C. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Qualitative research designs: Selection and implementation
John W. Creswell et al.
COUNSELING PSYCHOLOGIST (2007)
Genetic susceptibility testing for Alzheimer disease: Motivation to obtain information and control as precursors to coping with increased risk
Holly C. Gooding et al.
PATIENT EDUCATION AND COUNSELING (2006)
Genetic risk assessment for adult children of people with Alzheimer's disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study
JS Roberts et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Three approaches to qualitative content analysis
HF Hsieh et al.
QUALITATIVE HEALTH RESEARCH (2005)
Adverse effects of predictive testing for Huntington disease underestimated: Long-term effects 7-10 years after the test
R Timman et al.
HEALTH PSYCHOLOGY (2004)
分享论文
